Silicon Investor - Vion (formerly Oncorx) interesting play on Gene TherapyCopyright © 2013 Knight Sac Media. All rights reserved.http://www.siliconinvestor.com/subject.aspx?subjectid=3208 Vion (OCRX) is a R&D biotech company with several near and intermediate term product developments. For example, it has licensed from Yale University, exclusive rights to patent applications on several antiviral agents having activity against Hepatits B Virus (HBV), HIV, FddC and others. Vion has ...http://www.siliconinvestor.com/images/Logo380x132.pngSI - Vion (formerly Oncorx) interesting play on Gene Therapyhttp://www.siliconinvestor.com/subject.aspx?subjectid=320838013210